MMP17 and polycystic ovary syndrome: MMP-17 is reported to be expressed in the endometrium in a cycle-dependent manner that corresponds with high angiogenic activity [64], and the altered ratios reported here may contribute to the angiogenic dysregulation associated with PCOS [65].